Ishares U S Pharmaceuticals Etf Stock (IHE) Forecast
The Ishares U S Pharmaceuticals Etf (IHE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $110.50, representing a -0.70% decrease from the current price of $111.28. The highest analyst price target is $112.72, and the lowest is $108.29.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
Is Ishares U S Pharmaceuticals Etf (IHE) A Buy Now?
According to our latest analysis, IHE could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on IHE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 67.08 indicates that IHE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 78.78 indicates that IHE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 90.51 indicates that IHE is overbought. This suggests that IHE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 30.84 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of 85.65 indicates that IHE is still overbought but not to an extreme extent.
Long-term IHE price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ishares U S Pharmaceuticals Etf financial reports and earnings history, Ishares U S Pharmaceuticals Etf (IHE) stock could reach $140.51 by 2030, $252.29 by 2040 and $332.16 by 2050. See the projected annual prices until 2050 of the Ishares U S Pharmaceuticals Etf stock below:
- Ishares U S Pharmaceuticals Etf (IHE) is expected to reach an average price of $199.37 in 2035, with a high prediction of $201.80 and a low estimate of $180.78. This indicates an +79.16% change from the last recorded price of $111.28.
- Ishares U S Pharmaceuticals Etf (IHE) stock is projected to chart a bullish course in 2040, with an average price target of $248.04, representing an +122.90% change from its current level. The forecast ranges from a conservative $225.18 to a sky-high $252.29.
- Our analysts predict Ishares U S Pharmaceuticals Etf (IHE) to change +164.24% by 2045, soaring from $267.64 to an average price of $294.05, potentially reaching $294.62. While $267.64 is the low estimate, the potential upside is significant.
- Ishares U S Pharmaceuticals Etf (IHE) stock is expected to climb by 2050, reaching an average of $331.47, a +197.87% change from its current level. However, a wide range of estimates exists, with high and low targets of $332.16 and $305.74, respectively, highlighting the market's uncertainty.
Ishares U S Pharmaceuticals Etf Stock (IHE) Year by Year Forecast
Ishares U S Pharmaceuticals Etf Stock (IHE) Price Forecast for 2026
The predicted value for Ishares U S Pharmaceuticals Etf (IHE) in 2026 is set at an average of $98.23. Estimates vary from a peak of $112.72 to a trough of $83.03, indicating an -11.73% surge from the present price of $111.28.
Ishares U S Pharmaceuticals Etf Stock (IHE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ishares U S Pharmaceuticals Etf (IHE) is $111.73, with a high forecast of $116.18 and a low forecast of $106.70. This indicates an +0.41% increase from the last price of $111.28.
Ishares U S Pharmaceuticals Etf Stock (IHE) Price Forecast for 2028
In 2028, Ishares U S Pharmaceuticals Etf (IHE) is projected to reach an average price of $116.01, with a high projection of $121.61 and a low estimate of $110.76. This indicates an +4.25% rise from the last price of $111.28.
Ishares U S Pharmaceuticals Etf Stock (IHE) Price Forecast for 2029
The 2029 price forecast for Ishares U S Pharmaceuticals Etf Stock (IHE) is $125.07 on average, with a high prediction of $132.95 and a low estimate of $113.94. This represents an +12.40% increase from the previous price of $111.28.
Ishares U S Pharmaceuticals Etf Stock (IHE) Price Forecast for 2030
Ishares U S Pharmaceuticals Etf Stock (IHE) is expected to reach an average price of $134.12 in 2030, with a high forecast of $140.51 and a low forecast of $126.86. This signifies an +20.52% surge from the last price of $111.28.